RegAsk, a Healthcare RegTech Startup, Secures Venture Capital Funding in a Seed Round to Pursue Growth

RegAsk uses artificial intelligence to answer regulatory questions, including inquiries about path-to-market, path-to-claim, product registration and regulatory strategy. … Read More 

Save the Date: TKS 1 Investor Day 2019 in Singapore

We are pleased to announce our TKS 1 Investor Day in Singapore. The event will occur on Friday, January 25, 2019 and will include presentations from our portfolio companies, followed by Q&A sessions. … Read More 

Evid Science Receives Seed Capital to Advance Clinical AI Platform

LOS ANGELES, CA (February 15, 2018) – Evid Science, an artificial intelligence (AI) company for the pharmaceutical industry, has successfully secured seed funding from TKS I, a new private equity fund dedicated to early stage life science companies. “Our technology … Read More 

Duke-NUS Commercializes Discovery to Deliver Therapeutics Across Blood Brain Barrier

Intellectual property (IP) derived from discoveries made at Duke-NUS Medical School (Duke-NUS) have been licensed to a newly formed biotech start-up, Travecta Therapeutics Pte Ltd, a Singapore-based drug discovery company. Travecta plans to use the Duke-NUS technology to develop new … Read More 

Tackling the blood-brain barrier: Duke-NUS discovery leads to startup Travecta

HONG KONG – Travecta Therapeutics Pte Ltd. is the latest startup to join Singapore’s biotech block. The newly formed drug discovery company is based on intellectual property derived from discoveries made at Duke-NUS Medical School (Duke-NUS). Travecta is based on … Read More 

Travecta Therapeutics Appoints Douglas C. Hicks as Chief Business Officer

PHILADELPHIA — Sept. 13 2018 – Travecta Therapeutics, an emerging biotech company developing a platform that leverages its proprietary knowledge of the MFSD2a Transport for the targeted delivery of therapeutic agents across the blood-brain barrier, announces it has appointed Douglas … Read More 

The Role of E-commerce in Product Innovation

A R&D Guide Outlining Ways To Use E-commerce For A More Effective Analysis On A Future Product’s Success. … Read More 

This is why your patient engagement dollars are wasted.

A Patient (and consultant’s) Point-of-View on Patient Services Imagine, as a patient, you leave the doctor’s office having been diagnosed with a chronic disease. The treatment calls for heavy doses of medication and changed lifestyle habits. You pestered the doctor … Read More 

The Forgotten Piece to the Adherence Puzzle

Medicines don’t work if patients don’t take them. It’s one of the biggest culprits in healthcare’s nearly $300 billion problem. Estimates show poor adherence causes approximately 125,000 deaths and at least 10 percent of hospitalizations annually. Patient Engagement Programs Pharma companies are actively … Read More 

Forbes: ObvioHealth To Transform Clinical Studies

ObvioHealth, supported by SPRIM, releases a Mobile App that is positioned to transform clinical studies globally. … Read More 

ObvioHealth Announces Mobile Application

ORLANDO, Fla.–(BUSINESS WIRE)–ObvioHealth, a global medical technology company, announces the launch of its mobile application for site-less clinical studies—ClaimIt. ClaimIt removes barriers currently troubling the clinical research industry by improving convenience for study subjects, enhancing compliance, lowering drop-out rates and … Read More 

5 Big Product Development Mistakes

Failure rates of new product launches vary by industry, but most stats hover at or just below the 50 percent mark. There are dozens of reasons for these failures, and our engagement leaders see them daily. The categories where our clients … Read More 

ObvioHealth Raises $3 Million in Series A Funding

ObvioHealth, a Singapore and Orlando-based company offering mobile and “site-less” clinical trials, said on Friday it has raised US$3 million in Series A funding. The company is focused on making clinical trials faster and more cost-effective by digitizing the entire process … Read More